![Eric Adams](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Eric Adams
Directeur Général chez INMED PHARMACEUTICALS INC.
Fortune : 11 693 $ au 30/06/2024
Postes actifs de Eric Adams
Sociétés | Poste | Début | Fin |
---|---|---|---|
INMED PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 16/06/2016 | - |
Directeur Général | 16/06/2016 | - | |
President | 16/06/2016 | - |
Historique de carrière de Eric Adams
Anciens postes connus de Eric Adams
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ronin8 Technologies Ltd.
![]() Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Ronin8 Technologies Ltd. provides materials recovery facilities. It captures the metals in electronic waste without destroying the non-metals. The company was founded by Bruce Sifton and Peter Holgate in 2015 and is headquartered in Vancouver, Canada. | Directeur Général | 01/11/2014 | 01/02/2015 |
enGene, Inc.
![]() enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Directeur/Membre du Conseil | 25/05/2011 | 01/07/2013 |
Directeur Général | 15/03/2004 | 01/07/2013 | |
President | 15/03/2004 | 25/10/2011 | |
QLT, Inc.
![]() QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Sales & Marketing | 01/02/1998 | 01/12/2002 |
ABBOTT LABORATORIES | Corporate Officer/Principal | 01/08/1992 | 01/08/1996 |
FRESENIUS SE & CO. KGAA | Corporate Officer/Principal | 01/06/1988 | 01/06/1992 |
Formation de Eric Adams
University of South Carolina | Graduate Degree |
University of Southern Indiana | Undergraduate Degree |
Statistiques
Internationale
Canada | 5 |
Etats-Unis | 4 |
Allemagne | 2 |
Opérationnelle
Chief Executive Officer | 3 |
Director/Board Member | 2 |
President | 2 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
ABBOTT LABORATORIES | Health Technology |
FRESENIUS SE & CO. KGAA | Health Technology |
INMED PHARMACEUTICALS INC. | Health Technology |
Entreprise privées | 3 |
---|---|
enGene, Inc.
![]() enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Health Technology |
QLT, Inc.
![]() QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Ronin8 Technologies Ltd.
![]() Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Ronin8 Technologies Ltd. provides materials recovery facilities. It captures the metals in electronic waste without destroying the non-metals. The company was founded by Bruce Sifton and Peter Holgate in 2015 and is headquartered in Vancouver, Canada. | Industrial Services |
- Bourse
- Insiders
- Eric Adams
- Expérience